openPR Logo
Press release

Ischemic Heart Disease Market of ME&A by 2022 Key Players: HeartWare, AstraZeneca, Sanofi, American Hospital Dubai

12-19-2017 12:47 PM CET | Health & Medicine

Press release from: Market Research Future

Ischemic Heart Disease

Ischemic Heart Disease

Ischemic Heart Disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease. According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Middle-East and Africa Ischemic Heart Disease Market is increasing continuously.

Get Sample @ https://www.marketresearchfuture.com/sample_request/2585 .

Prevention is by regular exercise, maintaining a healthy weight and not smoking. Fruits and vegetables are healthy for body and it decreases the risk of cardiovascular disease and death. On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others. The market is growing at the CAGR of 3.1% and expected to reach to US$ 2.84 billion by 2022.

Ischemic heart Disease Market Companies Involved:

HeartWare (U.S.), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), Ganzouri Specialized Hospital (Egypt), AstraZeneca (U.K.), Sanofi (France), Merck Sharp & Dohme Corp.(U.S.), AUM Cardiovascular (US), American Hospital Dubai.

Ischemic Heart Disease Market Study Aim of Middle-East and Africa:    

To provide country level analysis of the market for segments by type, by diagnosis, by treatment type and its sub-segments. To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Ischemic heart Disease market. To provide country level analysis of the market with respect to the current market size and future prospective.

Browse Report @ https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585 .

Regional Analysis of Middle-East and Africa Ischemic heart Disease Market:

According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart Disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

List of Tables:
Table 1 Middle East And Africa Anti-Fungal Agents Market, 2013-2022 (USD Million)
Table 2 Middle East And Africa Anti-Fungal Agents Market, By Therapeutic Indication, 2013-2022 (USD Million)
Table 3 Middle East And Africa Anti-Fungal Agents Market, By Drug Class, 2013-2022 (USD Million)
Table 4 Middle East And Africa Anti-Fungal Agents Market, By Route Of Administration, 2013-2022 (USD Million)
Table 5 Middle East And Africa Anti-Fungal Agents Market, By Region, 2013-2022 (USD MILLION)

Get Discount @ https://www.marketresearchfuture.com/check-discount/2585 .  

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ischemic Heart Disease Market of ME&A by 2022 Key Players: HeartWare, AstraZeneca, Sanofi, American Hospital Dubai here

News-ID: 867877 • Views:

More Releases from Market Research Future

Airport Passenger Screening Systems Market to Reach USD 8.7 Billion by 2032, Gro …
Airport Passenger Screening Systems Market Outlook The global airport passenger screening systems market is witnessing strong momentum as the aviation industry continues to prioritize passenger safety, operational efficiency, and compliance with international security standards. According to recent market insights, the airport passenger screening systems market was valued at USD 5.76 billion in 2023 and is expected to reach USD 8.7 billion by 2032, expanding at a CAGR of 4.68% during the
Japan Hearing Aids Market Projected to Hit USD 1,720.0 Million by 2035, at an Exceptional CAGR of 9.128%
Japan Hearing Aids Market Projected to Hit USD 1,720.0 Million by 2035, at an Ex …
Introduction: A Growing Priority for Hearing Wellness Japan's aging population is accelerating demand for advanced hearing solutions. A thorough analysis shows that more than 14% of Japan's elderly population faces some form of hearing impairment, making hearing aids not just a medical device but a lifestyle necessity. With the Japan Hearing Aids Market projected to hit USD 1,720.0 million by 2035, at an exceptional CAGR of 9.128%, the industry is on
Italy Digital Healthcare Market Size, Growth Drivers and Global Forecast 2035 | At a Thriving CAGR of 21.48%
Italy Digital Healthcare Market Size, Growth Drivers and Global Forecast 2035 | …
Introduction: Digital Shift in Italian Healthcare Italy is rapidly transforming its healthcare system through digital integration, reflecting a broader European push for modernization. An in-depth analysis shows that digital healthcare adoption is growing across hospitals, clinics, and public health services. With the Italy Digital Healthcare Market projected to grow at a thriving CAGR of 21.48% by 2035, the nation is positioning itself as a hub of digital medical innovation. Download the Sample PDF
Sodium Sulphate Market Positioned for 4.10% CAGR Growth, Hitting USD 6.99 Billion by 2034
Sodium Sulphate Market Positioned for 4.10% CAGR Growth, Hitting USD 6.99 Billio …
The global sodium sulphate market was valued at USD 4.7 billion in 2024 and is projected to increase from USD 4.89 billion in 2025 to USD 6.99 billion by 2034. This growth represents a compound annual growth rate (CAGR) of 4.10% during the forecast period (2025-2034). The market's growth is heavily influenced by industrialization, particularly in emerging economies, and the continuous demand from key end-use industries. Get Sample @ https://www.marketresearchfuture.com/sample_request/30442 Market

All 5 Releases


More Releases for Ischemic

Rising Hypertension Fuels Growth In Acute Ischemic Stroke Therapeutics Market: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Acute Ischemic Stroke Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for acute ischemic stroke therapeutics has seen appreciable growth lately. Its expansion is expected to proceed from $9.24 billion in 2024 to about $10.12 billion in 2025, manifesting a compound
Rising Hypertension Fuels Growth In Acute Ischemic Stroke Therapeutics Market: K …
The Acute Ischemic Stroke Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Acute Ischemic Stroke Therapeutics Market Size During the Forecast Period? The acute ischemic stroke therapeutics market has experienced significant growth in recent years. It is projected to rise from
Ischemic Stroke Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Ischemic Stroke Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Ischemic Stroke pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Ischemic Stroke Pipeline Report • Over 50+ Ischemic Stroke
Ischemic Cardiomyopathy Treatment Market Growth, Challenges, Opportunities and E …
"The new report has been added by qyresearch.com to provide detailed insight into the global Ischemic Cardiomyopathy Treatment market. The study will help to get a better understanding about the Ischemic Cardiomyopathy Treatment industry competitors, a channel for the distribution, Ischemic Cardiomyopathy Treatment growth potential, potentially disruptive trends, Ischemic Cardiomyopathy Treatment industry product innovations, market size value/volume (regional/country level, Ischemic Cardiomyopathy Treatment industry segments), market share of top players/products. Due to
Transient Ischemic Attack Market Forecast by 2025
Recent Transient Ischemic Attack market research and the current scenario as well as future market potential of "Global Transient Ischemic Attack Market Professional Survey Report 2020". The Transient Ischemic Attack Market comprehensively describes the market and prognosticates it to describe a highly illustrious growth during the anticipated years. The report offers an in-depth analysis of current and future Transient Ischemic Attack Market outlook across the globe. The report is projected
Acute Ischemic Stroke Diagnosis And Treatment Market : Increased Usage of Advanc …
A recent report on global acute ischemic stroke diagnosis and treatment market has been analyzed by Transparency Market Research (TMR). The market for acute ischemic stroke diagnosis and treatment is expected to increase during the forecast period with the increasing incidence of strokes, technically advanced techniques, and successful results through treatment surgeries. Technological advancement and constant efforts made by leading companies are providing improved treatments for people suffering from ischemic